No black box warning on record for Roctavian

As of the latest FDA labeling reviewed, Roctavian (VALOCTOCOGENE ROXAPARVOVEC-RVOX) does not carry a black box warning. Standard warnings and precautions still apply — see the full Roctavian medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Infusion-related reactions: Infusion reactions, including hypersensitivity reactions and anaphylaxis, have occurred. Monitor during and for at least 3 hours after ROCTAVIAN administration. If symptoms occur, slow or interrupt administration and give appropriate treatment. Restart infusion at slower rate once symptoms resolve. Discontinue infusion for anaphylaxis. ( 2.3 ,

No black box warning on record for Roctavian

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Infusion-related reactions: Infusion reactions, including hypersensitivity reactions and anaphylaxis, have occurred. Monitor during and for at least 3 hours after ROCTAVIAN administration. If symptoms occur, slow or interrupt administration and give appropriate treatment. Restart infusion at slower rate once symptoms resolve. Discontinue infusion for anaphylaxis. ( 2.3 ,

Roctavian Black Box Warning

No black box warning on record for Roctavian

Other warnings & precautions

Roctavian Black Box Warning

No black box warning on record for Roctavian

Other warnings & precautions